These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36883744)

  • 1. Clinical assessment of SNIBE Maglumi SARS-CoV-2 antigen fully-automated chemiluminescent immunoassay.
    Pighi L; Henry BM; De Nitto S; Gianfilippi G; Salvagno GL; Plebani M; Lippi G
    Clin Chem Lab Med; 2023 Jul; 61(8):1506-1510. PubMed ID: 36883744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical and clinical evaluations of SNIBE Maglumi chemiluminescent immunoassay for the detection of SARS-CoV-2 antigen in salivary samples.
    Padoan A; Talli I; Cosma C; Moz S; Furlan G; Navaglia F; Marchioro L; Zaninotto M; Basso D; Plebani M
    Clin Chem Lab Med; 2024 Feb; 62(3):572-577. PubMed ID: 37787733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of ultrasensitive assay for SARS-CoV-2 antigen in nasopharynx in the management of COVID-19 patients with comorbidities during the peak of 2022 Shanghai epidemics in a tertiary hospital.
    Wang D; Lu H; Li Y; Shen J; Jiang G; Xiang J; Qin H; Guan M
    Clin Chem Lab Med; 2023 Feb; 61(3):510-520. PubMed ID: 36480433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical performance of Fujirebio Lumipulse G SARSCoV- 2 Ag chemiluminescent immunoassay.
    Salvagno GL; Henry BM; De Nitto S; Pighi L; Lippi G
    New Microbiol; 2022 Dec; 45(4):353-354. PubMed ID: 36538301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Berhane S; Taylor M; Adriano A; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Domen J; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; McInnes MD; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013705. PubMed ID: 33760236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit.
    Salvagno GL; Gianfilippi G; Pighi L; De Nitto S; Henry BM; Lippi G
    Adv Lab Med; 2021 Aug; 2(3):409-416. PubMed ID: 37362410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of Siemens SARS-CoV-2 Antigen (CoV2Ag) chemiluminescent immunoassay for diagnosing acute SARS-CoV-2 infection: a pooled analysis.
    Lippi G; Henry BM; Plebani M
    Clin Chem Lab Med; 2023 Jun; 61(7):1133-1139. PubMed ID: 36634305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical performance of the Roche Elecsys SARS-CoV-2 antigen fully automated electrochemiluminescence immunoassay.
    Salvagno GL; Pighi L; De Nitto S; Lippi G
    Pract Lab Med; 2022 Mar; 29():e00265. PubMed ID: 35071720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS® SARS-CoV-2 Antigen Test.
    Matsuzaki N; Orihara Y; Kodana M; Kitagawa Y; Matsuoka M; Kawamura R; Takeuchi S; Imai K; Tarumoto N; Maesaki S; Maeda T
    J Med Virol; 2021 Dec; 93(12):6778-6781. PubMed ID: 34170555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Field Evaluation of the New Rapid NG-Test
    Avgoulea K; Beredaki MI; Vourli S; Siopi M; Siafakas N; Pournaras S
    Front Public Health; 2022; 10():840984. PubMed ID: 35548072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Assessment of the DiaSorin LIAISON SARS-CoV-2 Ag Chemiluminescence Immunoassay.
    Salvagno GL; Gianfilippi G; Fiorio G; Pighi L; De Nitto S; Henry BM; Lippi G
    EJIFCC; 2021 Jun; 32(2):216-223. PubMed ID: 34421491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between viral load and positivization time of a SARS-CoV-2 rapid antigen test in routine nasopharyngeal specimens.
    Salvagno GL; Henry BM; de NS; Pighi L; Lippi G
    J Med Biochem; 2022 Oct; 41(4):513-517. PubMed ID: 36381068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical validation of quantitative SARS-CoV-2 antigen assays to estimate SARS-CoV-2 viral loads in nasopharyngeal swabs.
    Aoki K; Nagasawa T; Ishii Y; Yagi S; Okuma S; Kashiwagi K; Maeda T; Miyazaki T; Yoshizawa S; Tateda K
    J Infect Chemother; 2021 Apr; 27(4):613-616. PubMed ID: 33423918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of storage temperatures simulating transport conditions of nasopharyngeal swabs on the results of a chemiluminescence immunoassay (CLIA) to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen.
    Kanta P; Ghosh A; Goyal K; Kaur R; Baluni M; Sircar S; Kumar V; Kumar K; Vijay N; Singh MP
    Indian J Med Microbiol; 2023; 44():100379. PubMed ID: 37356827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical usefulness of fully automated chemiluminescent immunoassay for quantitative antibody measurements in COVID-19 patients.
    Soleimani R; Khourssaji M; Gruson D; Rodriguez-Villalobos H; Berghmans M; Belkhir L; Yombi JC; Kabamba-Mukadi B
    J Med Virol; 2021 Mar; 93(3):1465-1477. PubMed ID: 32797641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study.
    Horn MP; Jonsdottir HR; Brigger D; Damonti L; Suter-Riniker F; Endrich O; Froehlich TK; Fiedler M; Largiadèr CR; Marschall J; Weber B; Eggel A; Nagler M
    Allergy; 2022 Jul; 77(7):2090-2103. PubMed ID: 34986501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the Rapid Antigen Detection Kit with the Polymerase Chain Reaction for Detection of SARS-CoV-2 in Respiratory Samples].
    Erman Daloğlu A; Er H; Sepin Özen N; Çekin Y
    Mikrobiyol Bul; 2022 Apr; 56(2):263-273. PubMed ID: 35477229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).
    Nicol T; Lefeuvre C; Serri O; Pivert A; Joubaud F; Dubée V; Kouatchet A; Ducancelle A; Lunel-Fabiani F; Le Guillou-Guillemette H
    J Clin Virol; 2020 Aug; 129():104511. PubMed ID: 32593133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic performance of the fully automated Roche Elecsys SARS-CoV-2 antigen electrochemiluminescence immunoassay: a pooled analysis.
    Lippi G; Henry BM; Adeli K
    Clin Chem Lab Med; 2022 Apr; 60(5):655-661. PubMed ID: 35114742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world assessment of the clinical performance of COVID-VIRO ALL IN rapid SARS-CoV-2 antigen test.
    Pighi L; Henry BM; De Nitto S; Gianfilippi G; Salvagno GL; Lippi G
    Diagnosis (Berl); 2023 May; 10(2):187-192. PubMed ID: 36656638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.